June 2004 Table of Contents

External Link - article-97573.pdf

Articles in this issue

over 21 years ago

Article

Why Alliances Fail

over 21 years ago

Article

Hire Expectations

over 21 years ago

Article

DTC's Next Chapter

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!

Related Content

Lilly Enters Definitive Agreement Acquiring Aderum Biotechnologies

ByNicholas Jacobus

October 24th 2025

AI Becomes Pharma’s New Operating System: Q&A with causaLens’ CEO and Co-Founder Darko Matovski

ByNicholas Jacobus,Darko Matovski

October 24th 2025

TrumpRx and the Dawn of Direct-to-Consumer Commercialization

ByAmar Urhekar

October 24th 2025

Could DTC Programs Help Simplify the Drug-Pricing System?

ByMike Hollan,Chris O'Dell

October 24th 2025

Pharmaceutical Executive Daily: Novo Nordisk's Shares Fall After Board Shake-Up

ByNicholas Jacobus

October 23rd 2025

June 2004 Table of Contents

Articles in this issue

Newsletter

Related Content

Lilly Enters Definitive Agreement Acquiring Aderum Biotechnologies

AI Becomes Pharma’s New Operating System: Q&A with causaLens’ CEO and Co-Founder Darko Matovski

TrumpRx and the Dawn of Direct-to-Consumer Commercialization

Could DTC Programs Help Simplify the Drug-Pricing System?

Pharmaceutical Executive Daily: Novo Nordisk's Shares Fall After Board Shake-Up

Trending on PharmExec

TrumpRx and the Dawn of Direct-to-Consumer Commercialization

Could DTC Programs Help Simplify the Drug-Pricing System?

Pharmaceutical Executive Daily: Novo Nordisk's Shares Fall After Board Shake-Up

Roundup: Pharma Industry Raises Funding Aimed at Advancing the Development and Testing of Rare Disease Treatments

What Impact will DTC Programs Have on Prescription Drug Prices?